✦ LIBER ✦

Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer

✍ Scribed by Robert Jones, Jacqueline Vuky, Tony Elliott, Graham Mead, José Angel Arranz, John Chester, Simon Chowdhury, Arkadiusz Z. Dudek, Volker Müller-Mattheis, Marc-Oliver Grimm, Jürgen E. Gschwend, Christian Wülfing, Peter Albers, Jianguo Li, Anna Osmukhina, Jeffrey Skolnik, Gary Hudes…show all 17hide

Book ID: 120966761
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 210 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-013-9926-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Study to Assess the Safety, Tole

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors

✍ Taito Esaki; Takashi Seto; Hiroshi Ariyama; Shuji Arita; Chinatsu Fujimoto; Koic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

A Phase I study to assess the safety, to

A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

Phase I/II multicenter study to assess t

Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia

✍ H. M. Kantarjian, S. Padmanabhan, W. Stock, M. S. Tallman, G. A. Curt, J. Li, A. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 188 KB

Open, multi-center, phase IV study to as

Open, multi-center, phase IV study to assess the efficacy and tolerability of triptorelin in Taiwanese patients with advanced prostate cancer

✍ Chien-Chang Kao; Yen-Hwa Chang; Tony Wu; Guang-Huan Sun; Dah-Shyong Yu; Sun-Yran 📂 Article 📅 2012 🏛 Elsevier Science 🌐 Chinese ⚖ 361 KB

A Phase I study to assess the safety, ph

A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia

✍ Kosuke Tsuboi; Toshiya Yokozawa; Toru Sakura; Takashi Watanabe; Shin Fujisawa; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

A phase II, randomized, multicenter stud

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB